Marker Therapeutics (MRKR) Q1 2023 Earnings

15MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.8
-0.56
-0.32
-0.08

Details

Expected EPS
-0.8
Actual EPS
-0.57
Surprise EPS
0.23
Surprise Percent
+28.75%

Description

Marker Therapeutics (MRKR) has reported earnings of -0.57 per share for Q1 2023.

0 Comments

Share your thoughts